Industry News
Life Sciences
Top stories summarized by our editors
1/14/2022

A new TV ad from Pfizer for its COVID-19 vaccine never mentions the words "COVID-19" or "vaccine," but instead features scenes of everyday people living maskless and without fear. A second spot featuring Bruce Brown of the NBA's Brooklyn Nets focuses the importance of being vaccinated.

Full Story:
FiercePharma
1/14/2022

Another batch of 500,000 courses of the COVID-19 antibody cocktail Evusheld developed by AstraZeneca, which gained emergency use authorization from the FDA in December, was ordered by the Biden administration to boost protection among immunocompromised people against COVID-19, according to Jeff Zients, White House COVID-19 response coordinator. "The federal government was instrumental in the research and development of this product, and our latest order will also bring us to over 1 million doses available through [the] end of March," Zients said.

Full Story:
The Hill
More Summaries:
White House, Zients
1/14/2022

Endo is ending a successful 2019 Dupuytren's contracture campaign featuring former Denver Broncos star John Elway, and switching its focus to patients and their experiences. Endo markets the injectable drug Xiaflex for DC, a disease that causes collagen buildup in the hands and leaves fingers in a bent position.

Full Story:
FiercePharma
1/14/2022

An Indegene survey of about 1,000 physicians in the US, Europe, India and China found 70% said pharma sales representatives "do not completely understand their needs and expectations" and 62% were "overwhelmed" by product-related promos. The survey found 63% of physicians said drug companies should only share relevant content to "make the interactions more insightful."

Full Story:
FiercePharma
1/14/2022

Facebook rejected ads from 60 companies targeting women's sexual health, citing restrictions on sexual and reproductive health products, according to a new report from the Center for Intimacy Justice. Among the products and services were a breastfeeding workshop, postpartum pants and education on giving consent.

Full Story:
The New York Times
1/14/2022

-- Matt Eastwood of McCann Health commenting in a Muse by Clio article on creativity in the health care marketing.

Full Story:
Muse by Clio
1/14/2022

The National Institutes of Health has awarded Florida Atlantic University a three-year, $1.3 million grant to aid in the development of a sample-to-answer HIV self-test. The test would be able to deliver results within 40 minutes and would not need to be refrigerated.

1/14/2022

Johnson & Johnson has partnered with Microsoft to develop digital surgery solutions, including a surgical-monitoring dashboard. "Collaborating with Microsoft will help take our digital approach to the next level as we create a best-in-class, unified platform across our innovative surgical technologies," said J&J group Chief Information Officer and Global Vice President for Medical Devices Larry Jones.

Full Story:
MobiHealthNews
1/14/2022

A wearable personal COVID-19 exposure device has been developed by researchers from Yale University. "Our findings demonstrate that PDMS-based passive samplers may serve as a useful exposure assessment tool for airborne viral exposure in real-world high-risk settings and provide avenues for early detection of potential cases and guidance on site-specific infection control protocols that preempt community transmission," said the researchers.

More Summaries:
Yale University
1/14/2022

Researchers have developed AMBLor, a test that can predict the return or spread of skin cancer. "This test will aid clinicians to identify genuinely low-risk patients diagnosed with an early-stage melanoma and to reduce the number of follow-up appointments for those identified as low risk, saving the NHS time and money," said Penny Lovat, who led the research.

Full Story:
Sky News
More Summaries:
skin cancer